Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, Mariani L, Valagussa P, Miceli R, Stacchiotti S, Dei Tos AP, De Paoli A, Longhi A, Poveda A, Quagliuolo V, Comandone A, Casali PG, Picci P. Gronchi A, et al. Among authors: poveda a. J Clin Oncol. 2012 Mar 10;30(8):850-6. doi: 10.1200/JCO.2011.37.7218. Epub 2012 Feb 6. J Clin Oncol. 2012. PMID: 22312103 Clinical Trial.
Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcoma: a study of the Spanish Group for Research on Sarcomas (GEIS).
Buesa JM, Fra J, Antón A, López-Pousa A, Martín J, García del Muro J, Escudero P, Casado A, Poveda A. Buesa JM, et al. Among authors: poveda a. Ann Oncol. 1998 Jul;9(7):783-5. doi: 10.1023/a:1008243427528. Ann Oncol. 1998. PMID: 9739447 Free article. Clinical Trial. No abstract available.
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS).
Buesa JM, López-Pousa A, Martín J, Antón A, García del Muro J, Bellmunt J, Arranz F, Valentí V, Escudero P, Menéndez D, Casado A, Poveda A. Buesa JM, et al. Among authors: poveda a. Ann Oncol. 1998 Aug;9(8):871-6. doi: 10.1023/a:1008474802882. Ann Oncol. 1998. PMID: 9789610 Free article. Clinical Trial.
A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.
Garcia del Muro X, Lopez-Pousa A, Martin J, Buesa JM, Martinez-Trufero J, Casado A, Poveda A, Cruz J, Bover I, Maurel J; Spanish Group for Research on Sarcomas. Garcia del Muro X, et al. Among authors: poveda a. Cancer. 2005 Oct 15;104(8):1706-12. doi: 10.1002/cncr.21384. Cancer. 2005. PMID: 16134177 Free article. Clinical Trial.
Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, Maurel J, Calabuig S, Gutierrez A, González de Sande JL, Martínez J, De Juan A, Laínez N, Losa F, Alija V, Escudero P, Casado A, García P, Blanco R, Buesa JM; Spanish Group for Sarcoma Research. Martín J, et al. Among authors: poveda a. J Clin Oncol. 2005 Sep 1;23(25):6190-8. doi: 10.1200/JCO.2005.19.554. J Clin Oncol. 2005. PMID: 16135486
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.
López-Pousa A, Losa R, Martín J, Maurel J, Fra J, Sierra M, Casado A, García Del Muro J, Poveda A, Balañá C, Martínez-Trufero J, Esteban E, Buesa JM. López-Pousa A, et al. Among authors: poveda a. Br J Cancer. 2006 Jun 19;94(12):1797-802. doi: 10.1038/sj.bjc.6603187. Epub 2006 May 23. Br J Cancer. 2006. PMID: 16721358 Free PMC article. Clinical Trial.
Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX(R)/Doxil(R)) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS).
Poveda A, López-Pousa A, Martín J, Del Muro JG, Bernabé R, Casado A, Balañá C, Sanmartín O, Menéndez MD, Escudero P, Cruz J, Belyakova E, Menéndez D, Buesa JM. Poveda A, et al. Sarcoma. 2005;9(3-4):127-32. doi: 10.1080/13577140500287024. Sarcoma. 2005. PMID: 18521419 Free PMC article.
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
Maurel J, López-Pousa A, de Las Peñas R, Fra J, Martín J, Cruz J, Casado A, Poveda A, Martínez-Trufero J, Balañá C, Gómez MA, Cubedo R, Gallego O, Rubio-Viqueira B, Rubió J, Andrés R, Sevilla I, de la Cruz JJ, Del Muro XG, Buesa JM. Maurel J, et al. Among authors: poveda a. J Clin Oncol. 2009 Apr 10;27(11):1893-8. doi: 10.1200/JCO.2008.19.2930. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273704 Clinical Trial.
Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS).
Gronchi A, Judson I, Nishida T, Poveda A, Martin J, Reichardt P, Casali PG, Cesne AL, Hohenberger P, Blay JY. Gronchi A, et al. Among authors: poveda a. Eur J Cancer. 2009 May;45(7):1103-1106. doi: 10.1016/j.ejca.2009.02.009. Epub 2009 Mar 13. Eur J Cancer. 2009. PMID: 19286368 No abstract available.
259 results